Jeffrey Greve

Jeffrey Greve

Company: Kyverna Therapeutics

Job title: CSO


Developing synReg T Cells: Synthetic Tregs Targeted to Disease Tissues & Cells to Provide Transformative Treatments For Autoimmune Diseases 11:30 am

Creating synthetic Tregs by reprogramming CD4 T cells Sharing cell engineering strategies to direct synthetic Tregs to home to disease tissues and cells Developing a robust synReg manufacturing processRead more

day: Day two track 1 AM

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.